Rune Bergman
Chief Executive Officer presso Nordvacc Läkemedel AB
Posizioni attive di Rune Bergman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Nordvacc Läkemedel AB
 Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The private company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Chief Executive Officer | - | - |
Storia della carriera di Rune Bergman
Precedenti posizioni note di Rune Bergman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INTERVACC AB | Chairman | 01/01/2007 | 14/06/2018 |
| Founder | 01/01/2001 | 30/06/2019 | |
| Independent Dir/Board Member | 01/01/2001 | - | |
| Sales & Marketing | 01/01/2001 | 30/06/2019 |
Formazione di Rune Bergman
| Swedish University of Agricultural Sciences | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 4 |
Posizioni
| Chairman | 1 |
| Founder | 1 |
| Independent Dir/Board Member | 1 |
Settori
| Consumer Services | 2 |
| Health Technology | 2 |
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INTERVACC AB | Health Technology |
| Aziende private | 1 |
|---|---|
Nordvacc Läkemedel AB
Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The private company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Distribution Services |
- Borsa valori
- Insiders
- Rune Bergman
- Esperienza
